U.S. Electrical Stock News

Celldex Therapeutics recently reported first-quarter 2026 results, with revenue falling to US$15,000 from US$695,000 a year earlier and net loss widening to US$78.69 million, while accelerating investment in late-stage development of its lead antibody barzolvolimab. At the same time, Celldex completed Phase 3 enrollment for barzolvolimab in chronic spontaneous urticaria six months ahead of plan and raised about US$345 million in a follow-on offering, extending its funding runway for ongoing...

Shake Shack (SHAK) has been under pressure after first quarter results fell short on earnings and revenue, producing a rare operating loss as higher costs and regional disruptions weighed on profitability. See our latest analysis for Shake Shack. The sharp post earnings selloff is clear in the 7 day share price return of down 26.61% and 30 day return of down 28.87%. The 1 year total shareholder return of down 37.93% shows pressure has been building for some time, despite a new CFO appointment...

Franklin Electric (FELE) is back in focus after reporting first quarter 2026 results and reaffirming its full year net sales guidance, prompting investors to reassess the stock’s risk and income profile. See our latest analysis for Franklin Electric. At a share price of $99.34, Franklin Electric’s short term share price performance has been mixed, with the stock down 8.35% over 90 days but supported by a 1 year total shareholder return of 11.99%, suggesting momentum has cooled after earlier...

In early May 2026, Diebold Nixdorf reported first-quarter revenue of US$891.8 million and net income of US$5 million, while VyStar Credit Union expanded its partnership to adopt Diebold Nixdorf's Branch Automation Solutions and upgrade more than 200 ATMs with DN Series cash-recycling devices and advanced software features. The VyStar rollout highlights how Diebold Nixdorf’s artificial intelligence-driven managed services and analytics are being embedded deeper into client ATM networks,...

Key earnings details from Northeast Bank’s latest report Northeast Bank (NBN) posted third quarter results that highlighted year over year changes in profitability, including net interest income of US$63.07 million and net income of US$29.85 million for the period ended March 31, 2026. For the first nine months of the fiscal year, the bank reported net interest income of US$160.07 million and net income of US$73.14 million, giving investors fresh data to assess recent performance and earnings...

Ambarella recently announced that its co‑founder, president and CEO, Fermi Wang, received the inaugural 2026 IEEE Arun N. Netravali Video Analytics, Technology and Systems Award for his work in AI-powered video and edge analytics, underscoring the company’s technical contributions to this field. This recognition puts fresh attention on Ambarella’s edge AI system-on-chip platforms, highlighting how leadership in video analytics and AI processing underpins its semiconductor offering. We’ll now...

In early May 2026, Neurocrine Biosciences reported first‑quarter revenue of US$814.5 million and net income of US$197.9 million, alongside multiple clinical and real‑world updates for its endocrine and neuroscience portfolio, including CRENESSITY and a new obesity candidate NBIP‑’2118. Beyond the headline numbers, the first expert dosing algorithms and two‑year pediatric data for CRENESSITY suggest growing medical integration of the therapy in classic congenital adrenal hyperplasia care,...

Relay Therapeutics, Inc. recently reported first-quarter 2026 results showing revenue of US$3.00 million and a net loss of US$73.29 million, while outlining plans to advance its lead PI3Ka inhibitor zovegalisib with Pfizer’s atirmociclib into Phase 3 for frontline PI3Ka‑mutated, HR+/HER2- metastatic breast cancer. What stands out is that in heavily pre-treated patients, the zovegalisib triplet regimen showed an objective response rate approaching current first-line doublet therapies, which...

Procore Technologies (PCOR) is back in focus after its first quarter 2026 update, which combined higher revenue, a narrower net loss, raised full year guidance, fresh AI moves, and active share repurchases. See our latest analysis for Procore Technologies. Despite the stronger first quarter story and raised 2026 guidance, Procore Technologies' share price return is down 23.9% year to date and total shareholder return is down 26.2% over the past year. The 1 month share price return of 12.9%...

Sirius XM Holdings Inc. reported past first-quarter 2026 results, with revenue of US$2,091 million and net income of US$245 million, alongside higher basic and diluted earnings per share than a year earlier. A new advertising partnership with YouTube, allowing buyers to access YouTube’s audio inventory through Sirius XM’s adtech platform, signals a meaningful shift in how the company can monetize digital audio audiences. We’ll now examine how the YouTube ad partnership, alongside stronger...

Globant (NYSE:GLOB) is back in focus after a series of securities class action lawsuits alleged the company misled investors about its Latin American pivot, operational challenges, and subsequent restructuring. See our latest analysis for Globant. At a share price of US$39.23, Globant’s recent 1 day share price decline of 4.25% extends a weaker run, with the 30 day share price return down 9.32% and the 1 year total shareholder return down 71.65%. This suggests momentum has faded as investors...

In late April 2026, Brown-Forman Corporation announced it had realigned its U.S. control states distribution network, appointing four key distributors across 11 state-managed spirits markets while retaining existing partners in seven others. This reshaping of distributor relationships, following the end of merger discussions with Pernod Ricard, signals Brown-Forman’s focus on sharpening operational efficiency and market reach. We’ll now examine how this control states distribution overhaul...

Alvotech recently reported first-quarter 2026 results showing net income of US$1.03 million compared with US$109.68 million a year earlier, alongside a prior revenue decline tied to production slowdowns and facility improvements. Days later, the FDA completed a routine cGMP surveillance inspection of Alvotech’s Reykjavik site and issued a Form 483, which the company says involves remediable observations and supports its plan to resubmit key Biologics License Applications in 2026. We’ll now...

A federal judge’s dismissal of a securities lawsuit against MINISO Group Holding (MNSO) removes a legal overhang that had focused on its retail partner model and is prompting investors to reassess the stock’s recent underperformance. See our latest analysis for MINISO Group Holding. At a share price of US$14.63, the stock has seen short term pressure, with a 30 day share price return down 7.52% and a 90 day share price return down 23.92%. This feeds into a 1 year total shareholder return down...

Wondering whether NIKE at around US$44.14 is a bargain or a value trap? This article breaks down what the current price actually reflects. The stock has edged up 2.4% over the past week and 3.6% over the past month, yet is still down 30.2% year to date and 27.7% over the last year. Longer term 3 year and 5 year returns are also in decline at 61.0% and 65.1% respectively. Recent attention on NIKE has focused on how its share price performance compares with wider consumer durables stocks and...

Wondering whether AGI at around US$7.01 is a bargain or a value trap? This article walks through the key valuation clues that can help you frame that question. Over the last week the stock gained 2.9%, while over the past month it fell 1.3% and year to date it is down 34.8%. This naturally raises questions about how the market is currently pricing its prospects and risks. Recent coverage has focused on AGI's position in the US banking sector and how its share price has reacted to shifts in...

Melco Resorts & Entertainment (MLCO) is back on investors’ radar after reporting Q1 2026 results, with higher sales, revenue, and net income compared with a year earlier, along with fresh share repurchase activity. See our latest analysis for Melco Resorts & Entertainment. The recent Q1 results and new US$500 million buyback plan have arrived after a tougher stretch for investors, with the stock’s year to date share price return down 28.5% and the 1 year total shareholder return down 14.1%...

In the first quarter of 2026, Colgate-Palmolive reported sales of US$5,324 million, up from US$4,911 million a year earlier, while net income eased to US$646 million from US$690 million and diluted EPS slipped to US$0.80 from US$0.85. Despite pressure on margins from higher input costs, management kept its full-year 2026 net sales growth outlook of 2% to 6%, signaling confidence in its pricing and volume strategy across key markets. We’ll now examine how this combination of stronger sales,...

If you are wondering whether Salesforce at around US$181.82 is priced for opportunity or already reflects the story, an important starting point is understanding what the current valuation is really telling you. Over the short term the stock has been mixed, with a 7 day return that declined 2.0%, a 30 day gain of 10.2%, and a year to date fall of 28.3% that adds to a 36.6% decline over the past year. Recent headlines have focused on Salesforce as a large software player adjusting to changing...

Wondering if Axon Enterprise at around US$403.54 is offering value or just a rich price tag at this point? This article walks through the numbers so you can judge how the stock stacks up against its fundamentals. The stock has gained 2.5% over the past week and 16.7% over the past month, yet it is still down 28.4% year to date and 41.8% over the last year, after a very large 5 year return of about 3x. That mix of recent strength and longer term drawdown can change how you think about both...

Wondering if Halliburton stock at around US$39.83 still offers value, or if most of the easy gains are already behind it? This article breaks down what the current price might be implying. The share price has had a mixed short term patch, with the stock down 5.1% over the past week, up 6.0% over the last 30 days and showing returns of 34.6% year to date and 92.6% over the past year. Recent attention on Halliburton has centered on its position within the broader energy services sector and how...

Markel Insurance has appointed Raphael Da Costa to lead its U.S. cyber and technology E&O portfolio. The company has launched PlayMicro, a digital events insurance platform, in the Canadian market. Both moves highlight Markel Group's focus on specialty risks and digital distribution at NYSE:MKL. For investors watching NYSE:MKL, these moves come at a time when the stock trades around $1,814.64 and has been under pressure year to date, down 14.8%. Returns over longer periods are mixed, with...

RadNet Q1 2026 earnings: revenue expands while margins stay under pressure RadNet (RDNT) opened 2026 with Q1 revenue of US$575.6 million and a basic EPS loss of US$0.43, as the stock trades around US$58.19. The company has seen revenue move from US$471.4 million in Q1 2025 to US$575.6 million in Q1 2026, while quarterly EPS has shifted from a loss of US$0.51 to a loss of US$0.43 over the same period. This sets up a results season where investors are watching how quickly revenue scale can...

If you are wondering whether 3M at around US$143 a share still lines up with the value you are looking for, this breakdown will help you see how the current price compares with a range of valuation checks. The stock is up 1.2% over the last week, although it is down 4.7% over the last month, 11.5% year to date and 2.9% over the past year, with a very large 3 year return and a flat 0.1% return over 5 years, hinting at a mixed recent experience for shareholders. Recent headlines around 3M have...